CVS Health announces Pharmacy and Consumer Wellness leadership appointments
CVS Health has announced key leadership appointments in its Pharmacy and Consumer Wellness division. Len Shankman has been named president of Pharmacy and Consumer Wellness (PCW), overseeing front store and retail pharmacy operations across 9,000+ CVS Pharmacy locations. Lucille Accetta has been appointed chief pharmacy officer. Both will report to Prem Shah, group president. The company recently reported positive trends, including a record-high retail pharmacy prescription share of 27.3% and significant progress in transitioning to the CVS CostVantage model, with agreements covering over half of total commercial prescriptions.
CVS Health ha annunciato importanti nomine nella sua divisione Farmacia e Benessere dei Consumatori. Len Shankman è stato nominato presidente della Farmacia e Benessere dei Consumatori (PCW), supervisionando le operazioni nei negozi e nelle farmacie al dettaglio in oltre 9.000 località CVS Pharmacy. Lucille Accetta è stata nominata direttrice della farmacia. Entrambi riporteranno a Prem Shah, presidente di gruppo. L'azienda ha recentemente riportato tendenze positive, tra cui una quota record del 27,3% nelle ricette di farmacia al dettaglio e progressi significativi nella transizione al modello CVS CostVantage, con accordi che coprono oltre la metà delle ricette commerciali complessive.
CVS Health ha anunciado nombramientos clave en su división de Farmacia y Bienestar del Consumidor. Len Shankman ha sido nombrado presidente de Farmacia y Bienestar del Consumidor (PCW), supervisando las operaciones de la tienda y de la farmacia al por menor en más de 9,000 ubicaciones de CVS Pharmacy. Lucille Accetta ha sido designada directora de farmacia. Ambos reportarán a Prem Shah, presidente del grupo. La compañía ha informado recientemente de tendencias positivas, incluyendo un historial récord en la cuota de recetas de farmacia al por menor del 27,3% y un progreso significativo en la transición al modelo CVS CostVantage, con acuerdos que cubren más de la mitad de las recetas comerciales totales.
CVS Health는 약국 및 소비자 웰빙 부문에서 주요 인사 변동을 발표했습니다. Len Shankman이 약국 및 소비자 웰빙(PCW) 사장으로 임명되어 9,000개 이상의 CVS 약국 위치에서 매장 및 소매 약국 운영을 감독합니다. Lucille Accetta는 최고 약국 책임자로 임명되었습니다. 두 사람 모두 그룹 사장인 Prem Shah에게 보고합니다. 회사는 최근 27.3%의 기록적인 소매 약국 처방전 시장 점유율을 포함한 긍정적인 동향을 보고했으며, 전체 상업적 처방전의 절반 이상을 포함하는 CVS CostVantage 모델로의 전환에서도 큰 진전을 이루었습니다.
CVS Health a annoncé des nominations clés dans sa division Pharmacie et Bien-être des Consommateurs. Len Shankman a été nommé président de la Pharmacie et du Bien-être des Consommateurs (PCW), supervisant les opérations de magasin et de pharmacie de détail à travers plus de 9 000 emplacements CVS Pharmacy. Lucille Accetta a été nommée responsable de la pharmacie. Tous deux rendront compte à Prem Shah, président du groupe. L'entreprise a récemment signalé des tendances positives, y compris une part record de 27,3 % des prescriptions de pharmacie de détail et des progrès significatifs dans la transition vers le modèle CVS CostVantage, avec des accords couvrant plus de la moitié des prescriptions commerciales totales.
CVS Health hat wichtige Führungsänderungen in seiner Abteilung für Apotheke und Verbraucherwohlfahrt bekannt gegeben. Len Shankman wurde zum Präsidenten der Apotheke und des Verbraucherwohlstands (PCW) ernannt, verantwortlich für die Einzelhandels- und Apothekenoperationen an über 9.000 CVS Pharmacy Standorten. Lucille Accetta wurde zur Hauptapothekerin ernannt. Beide werden an Prem Shah, den Gruppenpräsidenten, berichten. Das Unternehmen hat kürzlich positive Trends gemeldet, darunter einen Rekordanteil von 27,3% im Einzelhandel mit verschreibungspflichtigen Medikamenten und signifikante Fortschritte beim Übergang zum CVS CostVantage-Modell, mit Vereinbarungen, die mehr als die Hälfte aller kommerziellen Verschreibungen abdecken.
- Record-high retail pharmacy prescription share of 27.3%
- Successful transition to CVS CostVantage model with agreements covering >50% of commercial prescriptions
- Strategic expansion of leadership team to strengthen pharmacy and retail operations
- None.
Insights
The leadership appointments at CVS Health, while appearing routine, carry strategic significance given the company's recent market performance. The 27.3% retail pharmacy prescription share marks a record high, indicating strong market positioning. The progress in implementing the CVS CostVantage model, now covering over 50% of commercial prescriptions, suggests a successful transition in their pricing strategy.
Shankman's appointment, with his financial background and specialty pharmacy experience, signals a continued focus on operational efficiency and digital transformation. The strategic emphasis on digitally-led experiences aligns with current healthcare consumer trends and could strengthen CVS's competitive position against both traditional competitors and digital healthcare disruptors.
As president, Pharmacy and Consumer Wellness, Shankman will oversee the front store and retail pharmacy businesses across the company's more than 9,000 CVS Pharmacy locations. In his new role, Shankman will lead the team in continuing to deliver integrated digitally-led experiences that address consumer's health and wellness needs when and where they need us.
Shankman joined CVS Health in 2002 and has held positions of increasing responsibility, most recently serving as senior vice president and chief financial officer, Pharmacy and Consumer Wellness. Shankman has also held leadership positions in the company's Specialty Pharmacy business and as general manager for Coram, the CVS Specialty infusion business. Before joining CVS Health, Shankman served in
"Len has a deep knowledge of our Pharmacy and Consumer Wellness business and our company, and his focus on strategy execution, operational strength, and financial performance will help us continue to lead in the market," said CVS Health president and CEO David Joyner. "His disciplined, strategic guidance will further position CVS Pharmacy as a trusted resource for the communities we serve."
As chief pharmacy officer, Accetta will advocate for the role of the pharmacist in health care and will be responsible for creating and implementing strategic opportunities to connect our pharmacy assets across the CVS Health enterprise. She will also continue to oversee the Specialty Pharmacy, Coram and Omnicare businesses in her role as senior vice president, Specialty Pharmacy Operations.
Since joining CVS Health in 2017, Accetta has held roles with increasing responsibility within the Specialty Pharmacy business. Prior to joining the company, she held leadership roles at Teva Pharmaceuticals, Rx Ally, Express Scripts and Medco, building her skills in patient services management, pharmacy product development and clinical operations.
"Our specialty pharmacy is entrusted with the care of people who are facing challenging and complex diagnoses, and Lucille leads with heart, driving the operational excellence our patients deserve along with instilling in our team an unwavering focus on caring for patients," said Joyner. "Her passion and commitment to the practice of pharmacy make her an excellent advocate for the profession."
On its most recent earnings call, the company highlighted recent positive trends in the Pharmacy and Consumer Wellness business:
- Our performance reflects strong execution and the benefit of strategic investments in both our workflows and our colleagues.
- We have achieved record high retail pharmacy prescription share of 27.3 percent.
- We continue to progress in the transition to the CVS CostVantage model, having reached agreements covering more than half of our total commercial prescriptions.
About CVS Health
CVS Health is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of September 30, 2024, the Company had more than 9,000 retail locations, more than 900 walk-in medical clinics, more than 225 primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs.
Media contact
Ethan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com
Investor contact
Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-announces-pharmacy-and-consumer-wellness-leadership-appointments-302320250.html
SOURCE CVS Health
FAQ
Who is the new president of Pharmacy and Consumer Wellness at CVS Health (CVS)?
What is CVS Health's (CVS) current retail pharmacy prescription share?
How much progress has CVS Health (CVS) made with the CostVantage model transition?
Who is the new chief pharmacy officer at CVS Health (CVS)?
